Mongolia Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mongolia Healthcare Journal.

Press releases published on October 9, 2026

28 minutes ago

Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer

Indeterminate GlobeNewswire

an hour ago

New Study Shows Cortical Disarray Measurement (CDM®) Can Reflect Microscopic Patterns of Pathology in Frontotemporal Dementia

Indeterminate GlobeNewswire

an hour ago

Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical

Indeterminate GlobeNewswire

an hour ago

Nuvectis Pharma to Participate in the Maxim Growth Summit 2026

Indeterminate GlobeNewswire

an hour ago

Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial

Indeterminate GlobeNewswire

an hour ago

Filana Therapeutics to Participate in the 2026 Maxim Growth Summit

Indeterminate GlobeNewswire

an hour ago

Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences

Indeterminate GlobeNewswire

an hour ago

Nextech Unveils Agentic AI Capabilities for Patient Experience through Partnerships with Assort Health and EliseAI

Indeterminate GlobeNewswire

an hour ago

Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease

Indeterminate GlobeNewswire

an hour ago

Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care

Indeterminate GlobeNewswire

an hour ago

Trillium Dental’s Dr. Mark Northcott Reveals Which Halloween Treats Damage Kids’ Teeth and Which Are Surprisingly Safe

Indeterminate GlobeNewswire

2 hours ago

Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference 

Indeterminate GlobeNewswire

2 hours ago

Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia

Indeterminate GlobeNewswire

2 hours ago

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

2 hours ago

Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermatology Conference

Indeterminate GlobeNewswire

4 hours ago

T·Time Launches Cash-Pay Compounded GLP-1 and GIP Injections With Flat Pricing

Indeterminate GlobeNewswire

4 hours ago

A promising new chapter for PI3Kδ inhibition: Nature Communications publications reveal novel mechanism behind iOnctura's roginolisib

Indeterminate GlobeNewswire

4 hours ago

Caregivers Need a Break: New No-Cost Day Program Opens in East St. Louis

Indeterminate GlobeNewswire

5 hours ago

Alumis Announces New Phase 3 Data Demonstrating Envudeucitinib Rapidly and Durably Improved Psoriasis Burden Across Scalp, Itch, and Quality of Life Measures

Indeterminate GlobeNewswire

9 hours ago

TherapiAI Showcases Agentic AI Platform for Biopharma at BioJapan 2026

Indeterminate GlobeNewswire